OMACETAXINE CYTOTOXIC ACTIVITY IN CHRONIC MYELOID LEUKAEMIA STEM CELLS

被引：0
|
作者：
Allan, E. K. [1 ]
Jorgensen, H. G. [2 ]
Michaels, S. [3 ]
Holyoake, T. L. [2 ]
机构：
[1] Scottish Natl Blood Transfus Serv, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Paul OGorman Leukaemia Res Ctr, Glasgow, Lanark, Scotland
[3] ChemGenex Pharmaceut Inc, Menlo Pk, CA USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1052
引用
收藏
页码：423 / 423
页数：1
相关论文
共 50 条
  • [21] Current role of stem cell transplantation in chronic myeloid leukaemia
    Gratwohl, Alois
    Heim, Dominik
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2009, 22 (03) : 431 - 443
  • [22] A Review of Omacetaxine: A Chronic Myeloid Leukemia Treatment Resurrected
    Winer, Eric S.
    DeAngelo, Daniel J.
    ONCOLOGY AND THERAPY, 2018, 6 (01) : 9 - 20
  • [23] Kinetics of stem cell engraftment and clearance of leukaemia cells after allogeneic stem cell transplantation with reduced intensity conditioning in chronic myeloid leukaemia
    Kreuzer, KA
    Schmidt, CA
    Schetelig, J
    Held, TK
    Thiede, C
    Ehninger, G
    Siegert, W
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 69 (01) : 7 - 10
  • [24] HTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia
    Campbell, LJ
    Fidler, C
    Eagleton, H
    Peniket, A
    Kusec, R
    Gal, S
    Littlewood, TJ
    Wainscoat, JS
    Boultwood, J
    LEUKEMIA, 2006, 20 (04) : 671 - 679
  • [25] hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia
    L J Campbell
    C Fidler
    H Eagleton
    A Peniket
    R Kusec
    S Gal
    T J Littlewood
    J S Wainscoat
    J Boultwood
    Leukemia, 2006, 20 : 671 - 679
  • [26] Role of Glutamine in the Modulation of the Sensitivity of Stem Cells of Chronic Myeloid Leukaemia Refractory to Standard Therapy
    Dello Sbarba, P.
    Poteti, M.
    Rovida, E.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (05): : S23 - S24
  • [27] Evaluation of drug combinations as a strategy to eradicate quiescent leukaemic stem cells in chronic myeloid leukaemia
    Jorgensen, H
    Allan, E
    Graham, S
    Richmond, L
    Godden, J
    Holyoake, T
    BRITISH JOURNAL OF CANCER, 2002, 86 : S27 - S27
  • [28] Development of donor cell derived acute myeloid leukaemia after stem cell transplantation for chronic myeloid leukaemia
    Pieroni, F
    Oliveira, FM
    Moraes, D
    Straccieri, ABPL
    Rodrigues, MC
    Panepucci, RA
    Voltarelli, JC
    Simoes, BP
    Falcao, RP
    BONE MARROW TRANSPLANTATION, 2006, 37 : S219 - S220
  • [29] Cytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-γ
    Schuerch, Christian
    Riether, Carsten
    Amrein, Michael A.
    Ochsenbein, Adrian F.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 210 (03): : 605 - 621
  • [30] Chronic myeloid leukaemia
    Cortes, Jorge
    Pavlovsky, Carolina
    Saussele, Susanne
    LANCET, 2021, 398 (10314): : 1914 - 1926
12345